NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

SkyLimit, you said:

In my view, IFR eligibility may soon become irrelevant with the pending MAA decision—but it’s still awesome to see that IFR access is now available while we await MHRA’s forthcoming decision!

But isn't it possible/likely that MHRA added Murcidencel/DCVax-L to the IFR program because they want to allow it to be used for patients with other cancers after DCVax-L MAA is completed/approved?? And couldn't results of these IFR cases lead to tumor -agnostic designation sooner rather than later?

PS: I enjoy reading your responses to Fudsters!